NCT03351322Phase 2Completed
ENERGI-F701 for Female Hair Loss Treatment
A Randomized, Double-Blind, Active-controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of ENERGI-F701 Solution in Female Subjects With Hair Loss
In the register
The register attaches this trial to ENERGI-F701 (Energenesis Biomedical), currently at “Phase 2” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Phase 2
- Sponsor
- Energenesis Biomedical Co., Ltd.
- Participants (registry)
- 67
- Start
- May 2018
- Primary completion
- November 2019
- Study completion
- December 2019
- Last registry update
- November 2020
- Countries
- Taiwan
Conditions studied: Female Pattern Baldness, Hair Loss, Alopecia
Interventions: ENERGI-F701, Regaine
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.